Discovery & Development

Digital twins in clinical trials are changing how research is performed – but it won’t be a revolution, according to Phesi CEO Gen Li.

The contribution of macaques to advancing human understanding of flu-like viruses, including H5N1, cannot be overstated.

We interview Lars Erwig, Director of the Centre of Drug Development at Cancer Research UK, about his career.

Research suggests diabetes patients using SGLT-2 and DPP-4 inhibitors have a decreased risk of developing dementia.

Nanorobots developed by engineers from the UK and China have delivered precision treatment to brain aneurysms

A recent US-based study discovered a new compound that could enhance naloxone’s ability to fend off more potent opioids.

A campaign to vaccinate children against polio in Gaza has begun, but success will depend on the vital role of the pharmaceutical industry.

The search for an effective treatment for childhood brain cancers goes on, but a modified Herpes virus could represent a breakthrough.

If used correctly, AI and ML expand our knowledge of biology and vastly improve the speed of success in the clinic.

We speak with the Alzheimer’s Society in the UK about their work. Find out more with The Medicine Maker